216 related articles for article (PubMed ID: 29038235)
21. Clinical Impact of Hybrid Capture-Based Next-Generation Sequencing on Changes in Treatment Decisions in Lung Cancer.
Rozenblum AB; Ilouze M; Dudnik E; Dvir A; Soussan-Gutman L; Geva S; Peled N
J Thorac Oncol; 2017 Feb; 12(2):258-268. PubMed ID: 27865871
[TBL] [Abstract][Full Text] [Related]
22. FOLFCIS Treatment and Genomic Correlates of Response in Advanced Anal Squamous Cell Cancer.
Mondaca S; Chatila WK; Bates D; Hechtman JF; Cercek A; Segal NH; Stadler ZK; Varghese AM; Kundra R; Capanu M; Shia J; Schultz N; Saltz L; Yaeger R
Clin Colorectal Cancer; 2019 Mar; 18(1):e39-e52. PubMed ID: 30316684
[TBL] [Abstract][Full Text] [Related]
23. Molecular tumor board: the University of California-San Diego Moores Cancer Center experience.
Schwaederle M; Parker BA; Schwab RB; Fanta PT; Boles SG; Daniels GA; Bazhenova LA; Subramanian R; Coutinho AC; Ojeda-Fournier H; Datnow B; Webster NJ; Lippman SM; Kurzrock R
Oncologist; 2014 Jun; 19(6):631-6. PubMed ID: 24797821
[TBL] [Abstract][Full Text] [Related]
24. Complete remission in metastatic breast cancer: expecting the unexpected-results of a cross-sectional study.
Galli G; Tessari A; Porcu L; Bregni G; Paolini B; Carcangiu ML; Gennaro M; De Santis MC; Lozza L; de Braud F; Di Cosimo S
Breast Cancer; 2017 Jul; 24(4):635-641. PubMed ID: 28058615
[TBL] [Abstract][Full Text] [Related]
25. Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve study.
Sicklick JK; Kato S; Okamura R; Patel H; Nikanjam M; Fanta PT; Hahn ME; De P; Williams C; Guido J; Solomon BM; McKay RR; Krie A; Boles SG; Ross JS; Lee JJ; Leyland-Jones B; Lippman SM; Kurzrock R
Genome Med; 2021 Oct; 13(1):155. PubMed ID: 34607609
[TBL] [Abstract][Full Text] [Related]
26. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.
Groisberg R; Hong DS; Holla V; Janku F; Piha-Paul S; Ravi V; Benjamin R; Kumar Patel S; Somaiah N; Conley A; Ali SM; Schrock AB; Ross JS; Stephens PJ; Miller VA; Sen S; Herzog C; Meric-Bernstam F; Subbiah V
Oncotarget; 2017 Jun; 8(24):39254-39267. PubMed ID: 28424409
[TBL] [Abstract][Full Text] [Related]
27. Prognostic implications of RAS alterations in diverse malignancies and impact of targeted therapies.
Kato S; Okamura R; Sicklick JK; Daniels GA; Hong DS; Goodman A; Weihe E; Lee S; Khalid N; Collier R; Mareboina M; Riviere P; Whitchurch TJ; Fanta PT; Lippman SM; Kurzrock R
Int J Cancer; 2020 Jun; 146(12):3450-3460. PubMed ID: 31782524
[TBL] [Abstract][Full Text] [Related]
28. Next-Generation Sequencing for Patients with Sarcoma: A Single Center Experience.
Cote GM; He J; Choy E
Oncologist; 2018 Feb; 23(2):234-242. PubMed ID: 28860410
[TBL] [Abstract][Full Text] [Related]
29. Comparison of efficacy and toxicity of first line chemotherapy with or without epirubicin for patients with advanced stage soft tissue sarcoma.
Cao J; Huang XE; Liu J; Wu XY; Lu YY
Asian Pac J Cancer Prev; 2013; 14(12):7171-7. PubMed ID: 24460271
[TBL] [Abstract][Full Text] [Related]
30. Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy.
Kato S; Kim KH; Lim HJ; Boichard A; Nikanjam M; Weihe E; Kuo DJ; Eskander RN; Goodman A; Galanina N; Fanta PT; Schwab RB; Shatsky R; Plaxe SC; Sharabi A; Stites E; Adashek JJ; Okamura R; Lee S; Lippman SM; Sicklick JK; Kurzrock R
Nat Commun; 2020 Oct; 11(1):4965. PubMed ID: 33009371
[TBL] [Abstract][Full Text] [Related]
31. Uterine Sarcoma: Clinical Presentation, Treatment and Survival Outcomes in Thailand.
Potikul C; Tangjitgamol S; Khunnarong J; Srijaipracharoen S; Thavaramara T; Pataradool K
Asian Pac J Cancer Prev; 2016; 17(4):1759-67. PubMed ID: 27221849
[TBL] [Abstract][Full Text] [Related]
32. Independent development of lymphoid and histiocytic malignancies from a shared early precursor.
Waanders E; Hebeda KM; Kamping EJ; Groenen PJ; Simons A; Hoischen A; Jongmans MC; Hoogerbrugge PM; van Leeuwen FN; Kuiper RP; Te Loo DM
Leukemia; 2016 Apr; 30(4):955-8. PubMed ID: 26202925
[No Abstract] [Full Text] [Related]
33. Clinical Usefulness of
Rinzivillo M; Partelli S; Prosperi D; Capurso G; Pizzichini P; Iannicelli E; Merola E; Muffatti F; Scopinaro F; Schillaci O; Salgarello M; Falconi M; Delle Fave G; Panzuto F
Oncologist; 2018 Feb; 23(2):186-192. PubMed ID: 29118267
[TBL] [Abstract][Full Text] [Related]
34. Molecularly matched therapy in the context of sensitivity, resistance, and safety; patient outcomes in end-stage cancer - the MetAction study.
Ree AH; Nygaard V; Boye K; Heinrich D; Dueland S; Bergheim IR; Johansen C; Beiske K; Negård A; Lund-Iversen M; Nygaard V; Hovig E; Nakken S; Nasser S; Julsrud L; Reisse CH; Ruud EA; Kristensen VN; Flørenes VA; Geitvik GA; Lingjærde OC; Børresen-Dale AL; Russnes HG; Mælandsmo GM; Flatmark K
Acta Oncol; 2020 Jul; 59(7):733-740. PubMed ID: 32208873
[No Abstract] [Full Text] [Related]
35. Routine application of next-generation sequencing testing in uro-oncology-Are we ready for the next step of personalised medicine?
Rodler S; Jung A; Greif PA; Rühlmann K; Apfelbeck M; Tamalunas A; Kretschmer A; Schulz GB; Szabados B; Stief C; Heinemann V; Westphalen CB; Casuscelli J
Eur J Cancer; 2021 Mar; 146():1-10. PubMed ID: 33535139
[TBL] [Abstract][Full Text] [Related]
36. Discordance in ER, PR, HER2, and Ki-67 Expression Between Primary and Recurrent/Metastatic Lesions in Patients with Primary Early Stage Breast Cancer and the Clinical Significance: Retrospective Analysis of 75 Cases.
Peng L; Zhang Z; Zhao D; Zhao J; Mao F; Sun Q
Pathol Oncol Res; 2021; 27():599894. PubMed ID: 34257555
[No Abstract] [Full Text] [Related]
37. Clinical correlates of blood-derived circulating tumor DNA in pancreatic cancer.
Patel H; Okamura R; Fanta P; Patel C; Lanman RB; Raymond VM; Kato S; Kurzrock R
J Hematol Oncol; 2019 Dec; 12(1):130. PubMed ID: 31801585
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAF
Dummer R; Brase JC; Garrett J; Campbell CD; Gasal E; Squires M; Gusenleitner D; Santinami M; Atkinson V; Mandalà M; Chiarion-Sileni V; Flaherty K; Larkin J; Robert C; Kefford R; Kirkwood JM; Hauschild A; Schadendorf D; Long GV
Lancet Oncol; 2020 Mar; 21(3):358-372. PubMed ID: 32007138
[TBL] [Abstract][Full Text] [Related]
39. [High dose chemotherapy with thiotepa, carboplatin, VP16 and autologous stem cell transplantation in treatment of malignant brain tumors with poor prognosis. Results of a mono-center pilot study].
Fleischhack G; Pöpping K; Hasan C; Utsch B; Jüttner J; Bode U
Klin Padiatr; 1998; 210(4):248-55. PubMed ID: 9743961
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological features of indonesian breast cancers with different molecular subtypes.
Widodo I; Dwianingsih EK; Triningsih E; Utoro T; Soeripto
Asian Pac J Cancer Prev; 2014; 15(15):6109-13. PubMed ID: 25124582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
